<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>126</id><JournalTitle>REVIEW ON HUNTINGTON DISEASE</JournalTitle><Abstract>Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by
unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. Prevalence in the Caucasian
population is estimated at 1/10,000-1/20,000. Mean age at onset of symptoms is 30-50 years. In some cases symptoms
start before the age of 20 years with behavior disturbances and learning difficulties at school (Juvenile Huntington's
disease). The classic sign is chorea that gradually spreads to all muscles. All psychomotor processes become severely
retarded. Patients experience psychiatric symptoms and cognitive decline. HD is an autosomal dominant inherited disease
caused by an elongated CAG repeat (36 repeats or more) on the short arm of chromosome 4 in the Huntington gene. The
longer the CAG repeat, the earlier the onset of disease. Diagnosis is based on clinical symptoms and signs in an individual
with a parent with proven HD, and is confirmed by DNA determination. Differential diagnoses include other causes of
chorea including general internal disorders or iatrogenic disorders. Phenocopies (clinically diagnosed cases of HD without
the genetic mutation) are observed. Prenatal diagnosis is possible by chorionic villus sampling or amniocentesis. There is
no cure. Management should be multidisciplinary and is based on treating symptoms with a view to improving quality of
life. Chorea is treated with dopamine receptor blocking or depleting agents. The progression of the disease leads to a
complete dependency in daily life, which results in patients requiring full-time care, and finally death. The most common
cause of death is pneumonia, followed by suicide</Abstract><Email>helenyelsa.8@gmail.com</Email><articletype>Review</articletype><volume>9</volume><issue>2</issue><year>2019</year><keyword>Neurodegenerative disorder,chorea,Juvenile Huntingtonâ€™s disease,autosomal dominant,phenocopies,dopamine receptor blocking agent</keyword><AUTHORS>Heleny Elsa Sunu,Hannah Joseph, Jiji Alfred</AUTHORS><afflication>Nazareth College of Pharmacy, Othera, Pathanamthitta District, Thiruvalla, Kerala 689546.,Nazareth College of Pharmacy, Othera, Pathanamthitta District, Thiruvalla, Kerala 689546.,Nazareth College of Pharmacy, Othera, Pathanamthitta District, Thiruvalla, Kerala 689546.</afflication></Article></Articles>